ArriVent BioPharma (NASDAQ:AVBP) Stock Quotes, Forecast and News Summary

Q: What sector and industry does ArriVent BioPharma (AVBP) operate in?

ArriVent BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ArriVent BioPharma Stock (NASDAQ: AVBP) stock price, news, charts, stock research, profile.

Open	$25.43
Close	$26.09
Volume / Avg.	662.70K / 225.69K
Day Range	$25.23 - $26.69
52 Wk Range	14.35 - 36.37
Market Cap	$879.16M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	40
Short Interest	13.8%
Days to Cover	19.32

Recent News

Discover the 3 Best-Performing Biotech IPO Stocks of 2024

Biotech and pharmaceutical companies are well known for raising capital through initial public offerings, or IPOs. Between 2001 and 2023, approximately 24% of IPOs were from biotech and pharmaceutical companies. When

MarketBeat

Here's What Could Help ArriVent BioPharma, Inc. Maintain Its Recent Price Strength

While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure the sustainability of a trend isn't easy.

Zacks

ProfoundBio Discovers The Joys Of Having A Wealthy Owner

Key Takeaways: Cancer treatment maker ProfoundBio announced it will be purchased by Denmark’s Genmab for $1.8 billion The deal is the fourth acquisition of a China-related innovative drugmaker by a foreign company in the last four months By Doug Young

The Bamboo Works

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Sep

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$25.43
Close	$26.09
Volume / Avg.	662.70K / 225.69K
Day Range	$25.23 - $26.69
52 Wk Range	14.35 - 36.37
Market Cap	$879.16M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	40
Short Interest	13.8%
Days to Cover	19.32

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy ArriVent BioPharma (AVBP) stock?

You can purchase shares of ArriVent BioPharma (NASDAQ:AVBP) through any online brokerage.

View our list of the best stock brokerages

Who are ArriVent BioPharma (AVBP) competitors?

Other companies in ArriVent BioPharma’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE) and Upstream Bio (NASDAQ:UPB).

What is the forecast, or price target, for ArriVent BioPharma (AVBP) stock?

ArriVent BioPharma has a consensus price target of $36.80.

What is the current price for ArriVent BioPharma (AVBP)?

The stock price for ArriVent BioPharma (NASDAQ: AVBP) is $26.09 last updated December 20, 2024 at 4:03 PM EST.

Does ArriVent BioPharma (AVBP) pay a dividend?

There are no upcoming dividends for ArriVent BioPharma.

When is ArriVent BioPharma (NASDAQ:AVBP) reporting earnings?

ArriVent BioPharma’s Q4 earnings are confirmed for Sunday, February 2, 2025.

Is ArriVent BioPharma (AVBP) going to split?

There is no upcoming split for ArriVent BioPharma.

What sector and industry does ArriVent BioPharma (AVBP) operate in?

ArriVent BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

ArriVent BioPharma

ArriVent BioPharma (AVBP) Forecast